Elisabete Oliveira

Summary

Affiliation: Institute of Molecular Pathology and Immunology
Country: Portugal

Publications

  1. ncbi request reprint Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique
    E Oliveira
    Institute of Pathology and Molecular Immunology of University of Porto, Porto, Portugal
    Eur J Clin Pharmacol 63:703-6. 2007
  2. ncbi request reprint The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal
    Elisabete Oliveira
    Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
    J Pediatr Hematol Oncol 27:425-9. 2005
  3. doi request reprint Pharmacogenetically relevant polymorphisms in Portugal
    E Oliveira
    University of Porto, Institute of Pathology and Molecular Immunology, 4200 465 Porto, Portugal
    Pharmacogenomics 8:703-12. 2007
  4. doi request reprint Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history
    Elisabete Oliveira
    Faculty of Sciences, University of Porto and IPATIMUP, 4200 465 Porto, Portugal
    Pharmacogenomics 10:1413-22. 2009
  5. ncbi request reprint Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population
    Slah Ouerhani
    Laboratory of Genetic, Immunology and Human Pathology, Faculty of Sciences of Tunis, El Mannar I, 2092 Tunis, Tunisia
    Cancer Genet Cytogenet 176:48-53. 2007

Detail Information

Publications5

  1. ncbi request reprint Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique
    E Oliveira
    Institute of Pathology and Molecular Immunology of University of Porto, Porto, Portugal
    Eur J Clin Pharmacol 63:703-6. 2007
    ....
  2. ncbi request reprint The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal
    Elisabete Oliveira
    Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
    J Pediatr Hematol Oncol 27:425-9. 2005
    ..Concerning MTHFR1298*C, this study failed to corroborate previous findings of decreased risk of ALL in the presence of the variant...
  3. doi request reprint Pharmacogenetically relevant polymorphisms in Portugal
    E Oliveira
    University of Porto, Institute of Pathology and Molecular Immunology, 4200 465 Porto, Portugal
    Pharmacogenomics 8:703-12. 2007
    ....
  4. doi request reprint Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history
    Elisabete Oliveira
    Faculty of Sciences, University of Porto and IPATIMUP, 4200 465 Porto, Portugal
    Pharmacogenomics 10:1413-22. 2009
    ..To help to fill this gap, this work characterized three previously uncharacterized African populations for a set of pharmacogenetically relevant polymorphisms...
  5. ncbi request reprint Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population
    Slah Ouerhani
    Laboratory of Genetic, Immunology and Human Pathology, Faculty of Sciences of Tunis, El Mannar I, 2092 Tunis, Tunisia
    Cancer Genet Cytogenet 176:48-53. 2007
    ..Patients harboring at least one mutant allele for each of the three positions analyzed showed a 4.76-fold increased risk of developing bladder cancer in comparison to their reference group (P = 0.02, OR = 4.76; CI 95% 1.26-17.98)...